Althea releases new investor presentation detailing European expansion and strategic growth plan Investment Highlights: ASX-listed global cannabis company with rapidly expanding operations in Europe, North America, Australia and Africa Vertically integrated with capabilities spanning the manufacturing, sales and distribution of pharmaceutical and non-pharmaceutical cannabis-based products Strong financial performance, news flow, and cash position Massive market opportunity - undervalued against...
Althea signs medicinal cannabis supply agreement with UK's Grow Pharma PR Newswire MELBOURNE, Australia, May 19, 2020 MELBOURNE, Australia , May 19, 2020 /PRNewswire/ -- Australian pharmaceutical company Althea Group Holdings Limited (ASX:AGH) ('Althea' or 'the Company') is pleased to announce it has executed a Medicinal Cannabis Supply Agreement (' agreement ') with UK-based Grow Pharma to import, sell and distribute Althea products in the UK. Grow Pharma (a joint venture of Grow Biotech and...
Althea Partners with UK Scientific Drug Committee to Further Education on Medicinal Cannabis and Improve Patient Access PR Newswire SYDNEY, May 23, 2019 Althea collaborates with Drug Science, the UK's only completely independent scientific committee on drugs, to further education on medicinal cannabis and improve patient access in the UK Drug Science will use Althea's recently launched learning portal MEDIC to educate healthcare professionals about medicinal cannabis Drug Science aims to have...
Watch our fixed income specialist Althea Spinozzi explain why sovereign bonds are set for a strong year, or download our full Quarterly Outlook here: ......
We expect three themes to threaten the tranquility of fixed-income investors in the final quarter of the year: persistent volatility in emerging markets, political ......
Ajinomoto Althea and OmniChem Combine to Form Ajinomoto Bio-Pharma Services, Reflecting a Collective Range of Services Offered to the Bio-Pharma Industry PR Newswire SAN DIEGO and WETTEREN, Belgium, Oct. 2, 2018 SAN DIEGO and WETTEREN, Belgium , Oct. 2, 2018 /PRNewswire/ -- Ajinomoto Althea and OmniChem, global leaders in large and small molecule contract manufacturing services, announced today that they are integrating their businesses and operations as a unified Contract Development and...
Ajinomoto Althea y OmniChem se combinan y forman Ajinomoto Bio-Pharma Services PR Newswire SAN DIEGO y WETTEREN, Bélgica, 2 de octubre de 2018 - Ajinomoto Althea y OmniChem se combinan y forman Ajinomoto Bio-Pharma Services para prestar una gama colectiva de servicios al sector biofarmacéutico SAN DIEGO y WETTEREN, Bélgica, 2 de octubre de 2018 /PRNewswire/ -- Ajinomoto Althea y OmniChem, líderes globales en servicios de fabricación por contrato de moléculas grandes y pequeñas, han...
Ajinomoto Althea et OmniChem s'unissent pour former la société Ajinomoto Bio-Pharma Services et proposer une gamme commune de services à l'industrie biopharmaceutique PR Newswire SAN DIEGO et WETTEREN, Belgique, 2 octobre 2018 SAN DIEGO et WETTEREN, Belgique, 2 octobre 2018 /PRNewswire/ -- Ajinomoto Althea et OmniChem, leaders mondiaux des services de fabrication en sous-traitance de petites et grandes molécules, ont annoncé aujourd'hui mettre en commun leurs activités et de leurs...
Ajinomoto Althea und OmniChem fusionieren zu Ajinomoto Bio-Pharma Services mit einem gemeinsamen Leistungsspektrum für die Biopharmabranche PR Newswire SAN DIEGO und WETTEREN, Belgien, 2. Oktober 2018 SAN DIEGO und WETTEREN, Belgien, 2. Oktober 2018 /PRNewswire/ -- Ajinomoto Althea und OmniChem, weltweit führende Anbieter von pharmazeutischen Auftragsfertigungsleistungen für große und kleine Moleküle, gaben heute bekannt, dass sie ihre Geschäfte und Aktivitäten im Rahmen einer...